A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in many types of tumors, https://bookmark-vip.com/story22059745/vhh-fragments-restore-the-p53-protein-the-new-pathway-for-cancer-treatment